A low-income housing cooperative for people with HIV and AIDS is fighting to stay open in San Francisco. On Sunday afternoon, ...
Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...
Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...
HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.
Already, significant harm has been done to inhibit progress combating HIV/AIDS, and the next four years could return us to ...
Without public health surveillance, officials trying to tackle outbreaks, identify threats and evaluate treatments are working ‘in the darkness of ignorance.’ ...
A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...
The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...
An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...
Prevalence varies by region and is impacted by social stigma, access to preventive medicine and a lack of HIV/AIDS education, ...
During the opening day of the Conference on Retroviruses and Opportunistic Infections, Rebecca Denison, a decades-long HIV ...
In an unprecedented crisis, a small town called Taunsa Sharif, located in South Punjab, is grappling with an alarming outbreak of HIV/AIDS among minor children aged from nine months to 10 years, with ...